Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Dysregulated Mirnas after Uniform Treatment Predict Outcome of Newly-Diagnosed Multiple Myeloma

Tessa Han, Stephane Minvielle, PhD, Anil Aktas Samur, PhD, Mariateresa Fulciniti, PhD, Florence Magrangeas, PhD, Paul G. Richardson, MD, Philippe Moreau, MD, Michel Attal, MD PhD, Kenneth C. Anderson, MD, Hervé Avet-Loiseau, MD PhD, Giovanni Parmigiani, PhD, Mehmet Kemal Samur, PhD, Nikhil C. Munshi, MD

Blood (2019) 134 (Supplement_1): 4348.

https://doi.org/10.1182/blood-2019-130343

Published: 2019

Journal Articles

Poor Prognosis Associated with Gains of CCND1 in Mantle Cell Lymphoma Treated By First Line Immuno-Chemotherapy — a Study By the Lysa Group

Blood (2018) 132 (Supplement 1): 4099.

https://doi.org/10.1182/blood-2018-99-113303

Published: 2018

Journal Articles

Correlations between p16 Protein Expression and Genomic Profile in Mantle Cell Lymphoma and Impact on Survival, a Lyma-Genomic Project Conducted on Behalf of the Lysa Group

Yannick LE Bris, MDPharmD, Danielle Canioni, MD, Barbara Burroni, MD, Anne Moreau, MD, Benoit Tessoulin, MD, Florence Magrangeas, PhD, Marie-Helene Delfau, MD, Catherine Thieblemont, MD, Lucie Oberic, MD, Krimo Bouabdallah, MD, Emmanuel Gyan, MD PhD, David Chiron, PhD, Catherine Pellat-deceunynck, PhD, Mary Callanan, PhD, Stephane Minvielle, PhD, Marie C Bene, PharmSci, PhD, Olivier Hermine, MD PhD, Steven Le Gouill, MD PhD

Blood (2018) 132 (Supplement 1): 2846.

https://doi.org/10.1182/blood-2018-99-113268

Published: 2018

Journal Articles

Deciphering the Chronology of Copy Number Alterations in Multiple Myeloma (MM): What Comes First?

Anil Aktas Samur, PhD, Mehmet Kemal Samur, PhD, Stephane Minvielle, PhD, Florence Magrangeas, PhD, Masood A. Shammas, PhD, Mariateresa Fulciniti, PhD, Michel Attal, MD PhD, Philippe Moreau, Kenneth Anderson, MD, Giovanni Parmigiani, Hervé Avet-Loiseau, MD PhD, Nikhil Munshi, MD

Blood (2018) 132 (Supplement 1): 3171.

https://doi.org/10.1182/blood-2018-99-120101

Published: 2018

Journal Articles

Landscape of Recurrent Mutations in Non-Coding Genome with Functional Implications in Newly-Diagnosed Multiple Myeloma

Mehmet Kemal Samur, PhD, Chandraditya Chakraborty, PhD, Raphael Szalat, MD, Anil Aktas Samur, PhD, Mariateresa Fulciniti, PhD, Michael A Lopez, Masood A. Shammas, PhD, Paul Richardson, Florence Magrangeas, PhD, Stephane Minvielle, PhD, Philippe Moreau, Michel Attal, Anjan Thakurta, PhD, Kenneth Anderson, MD, Giovanni Parmigiani, Hervé Avet-Loiseau, MDPhD, Nikhil Munshi, MD

Blood (2018) 132 (Supplement 1): 190.

https://doi.org/10.1182/blood-2018-190

Published: 2018

Journal Articles

Bone Marrow Microenvironment Regulates Alternative Splicing Events in Myeloma Cells through Downregulation of RNA Binding Protein Fox2

Blood (2014) 124 (21): 4714.

https://doi.org/10.1182/blood.V124.21.4714.4714

Published: 2014

Journal Articles

in Multiple Myeloma, High-Risk Features Are Modulated By Other Chromosomal changes : A Large Snparray IFM Study

Jill Corre, PharmD, PhD, Benjamin Hebraud, MD, Florence Magrangeas, PhD, Valérie Lauwers-Cances, MD, Marie-Lorraine Chretien, MD, Stephane Minvielle, PhD, Hervé Avet-Loiseau

Blood (2014) 124 (21): 641.

https://doi.org/10.1182/blood.V124.21.641.641

Published: 2014

Journal Articles

Functional and Molecular Impact Of Dp1-Dependent Alternate Splicing In Multiple Myeloma

Mariateresa Fulciniti, PhD, Manoj Bashin, Ph.D, Mehmet Kemal Samur, PhD, Rajya Bandi, Parantu K Shah, PhD, Antonia Cagnetta, MD, Cheng Li, PhD, Florence Magrangeas, PhD, Stephane Minvielle, PhD, Herve Avet-Loiseau, MD, Kenneth C. Anderson, MD, Nikhil C. Munshi, MD

Blood (2013) 122 (21): 1845.

https://doi.org/10.1182/blood.V122.21.1845.1845

Published: 2013

Journal Articles

Bone Marrow Microenvironment Affects The Pathogenesis Of Multiple Myeloma Through Downregulation Of Alternative Splicing Factor Fox2 In Myeloma Cells

Weihua Song, MD, Chaolin Zhang, PhD, Yiguo Hu, PhD, Maria Gkotzamanidou, MD, Parantu Shah, PhD, Weisong Shan, MD PhD, Guang Yang, PhD, Samir B. Amin, MBBS, Yu-Tzu Tai, PhD, Yi Li, PhD, Adam Sperling, MD, PhD, Naim Rashid, PhD, Florence Magrangeas, PhD, Stephane Minvielle, PhD, Hervé Avet-Loiseau, MD, PhD, Kenneth C. Anderson, MD, Cheng Li, PhD, Nikhil C. Munshi, MD

Blood (2013) 122 (21): 3085.

https://doi.org/10.1182/blood.V122.21.3085.3085

Published: 2013

Journal Articles

Low Level Of NF-Kb Activity Is Associated With Higher Response Rate To Bortezomib-Based Induction Therapy In Patients With Newly Diagnosed Multiple Myeloma

Florence Magrangeas, PhD, Philippe Moreau, MD, Loic Campion, MD, Herve Avet-Loiseau, MD, Catherine Guérin, Wilfried Gouraud, Gérald Marit, MD, Michel Attal, MD, Denis Caillot, MD, Thierry Facon, MD, Cyrille Hulin, MD, Lotfi Benboubker, MD, Brigitte Pegourie, MD, Stephane Minvielle, PhD

Blood (2013) 122 (21): 3106.

https://doi.org/10.1182/blood.V122.21.3106.3106

Published: 2013

Journal Articles

Cereblon (CRBN) Splicing Could Influence Response To IMiDs : A New PCR Strategy to Easily Detect and Semi-Quantify Loss Of The IMiDs Binding Domain

Blood (2013) 122 (21): 3107.

https://doi.org/10.1182/blood.V122.21.3107.3107

Published: 2013

Journal Articles

Whole Exome Sequencing Of Multiple Myeloma Reveals An Heterogeneous Clonal Architecture and Genomic Evolution

Blood (2013) 122 (21): 399.

https://doi.org/10.1182/blood.V122.21.399.399

Published: 2013

Journal Articles

First Large Prospective Study For Patients With Primary Plasma Cell Leukemia: Bortezomib-Doxorubicine-Dexamethasone/Bortezomib-Cyclophosphamide-Dexamethasone Regimens As Induction Before Stem Cell Transplantation Followed By Consolidation With Lenalidomide-Bortezomib-Dex Or Allograft. (a study of the IFM group)

Blood (2013) 122 (21): 761.

https://doi.org/10.1182/blood.V122.21.761.761

Published: 2013

Journal Articles

Characterization of TFDP1 As Novel Regulatory Gene in Multiple Myeloma

Mariateresa Fulciniti, PhD, Parantu K Shah, PhD, Rajya Bandi, Yi Li, PhD, Florence Magrangeas, PhD, Stephane Minvielle, PhD, Herve Avet-Loiseau, MD, Cheng Li, PhD, Kenneth C. Anderson, Nikhil C. Munshi, MD

Blood (2012) 120 (21): 569.

https://doi.org/10.1182/blood.V120.21.569.569

Published: 2012

Journal Articles

Gene Mutations Detected by Whole-Exome Sequencing and Recurrent Cytogenetic Abnormalities Are Independent Events in Multiple Myeloma

Hervè Avet-Loiseau, MD, PhD, Graham R Bignell, Cheng Li, PhD, Florence Magrangeas, PhD, Thierry Facon, MD, Michel Attal, MD, Kenneth C. Anderson, MD, Peter Campbell, Stephane Minvielle, PhD, Nikhil C. Munshi, MD, Andrew Futreal

Blood (2011) 118 (21): 1816.

https://doi.org/10.1182/blood.V118.21.1816.1816

Published: 2011

Journal Articles

Gene Expression Profile Alone Is Inadequate In Predicting Complete Responses In Multiple Myeloma

Samir B. Amin, MBBS, Stephane Minvielle, PhD, Bret Hanlon, PhD, Parantu K Shah, PhD, Cheng Li, PhD, Yi Li, PhD, David Swanson, PhD, Philippe Moreau, MD, Florence Magrangeas, PhD, Kenneth C. Anderson, MD, Hervé Avet-Loiseau, MD, PhD, Nikhil C. Munshi, MD

Blood (2010) 116 (21): 306.

https://doi.org/10.1182/blood.V116.21.306.306

Published: 2010

Journal Articles

Bortezomib Inhibits mTOR Pathway in Multiple Myeloma Cell Lines Via Induced Expression of REDD1.

Olivier Decaux, MD, Monique Clement, PhD, Florence Magrangeas, PhD, Laurence Lode, MD, Catherine Charbonnel, Wilfried Goureau, Herve Avet Loiseau, MD, PhD, Stephane Minvielle, PhD

Blood (2007) 110 (11): 242.

https://doi.org/10.1182/blood.V110.11.242.242

Published: 2007

Journal Articles

High-Resolution Genomic Profiles Identify Novel Genes and/or Chromosomal Regions with Prognostic and Oncogenic Significance in Myeloma Patients.

Herve Avet Loiseau, MD, PhD, Nikhil C. Munshi, MD, Cheng Li, Florence Magrangeas, PhD, Wilfried Gouraud, PhD, Catherine Charbonnel, PhD, Jean-Luc Harousseau, MD, Michel Attal, MD, PRD, Gerald Marit, MD, Claire Mathiot, MD, Thierry Facon, MD, Philippe Moreau, MD, Kenneth C. Anderson, MD, Stephane Minvielle, PhD

Blood (2007) 110 (11): 657.

https://doi.org/10.1182/blood.V110.11.657.657

Published: 2007

Journal Articles

Molecular Prognosis in Multiple Myeloma: The IFM Experience.

Olivier Decaux, MD, Florence Magrangeas, PhD, Laurence Lode, PharmD, Catherine Charbonnel, Wilfried Gouraud, Philippe Moreau, MD, Jean-Luc Harousseau, MD, Michel Attal, MD, Regis Bataille, MD, PhD, Loic Campion, MD, Herve Avet Loiseau, MD, PhD, Stephane Minvielle, PhD

Blood (2006) 108 (11): 3491.

https://doi.org/10.1182/blood.V108.11.3491.3491

Published: 2006

Journal Articles

Gene Expression Profiling Comparison between the Major Mature B-Cell Neoplasms and Their Normal Cellular and Anatomic Counterparts: Identification of Candidate Genes Potentially Involved in Lymphomagenesis.

Nicolas Blin, MD, Celine Bossard, MD, Jean-Luc Harousseau, MD, Catherine Charbonnel, Wilfried Gouraud, Loic Campion, MD, Florence Magrangeas, PhD, Stephane Minvielle, PhD, Herve Avet Loiseau, MD,PhD

Blood (2006) 108 (11): 2375.

https://doi.org/10.1182/blood.V108.11.2375.2375

Published: 2006

NARROW

Dysregulated Mirnas after Uniform Treatment Predict Outcome of Newly-Diagnosed Multiple Myeloma

Poor Prognosis Associated with Gains of CCND1 in Mantle Cell Lymphoma Treated By First Line Immuno-Chemotherapy — a Study By the Lysa Group

Correlations between p16 Protein Expression and Genomic Profile in Mantle Cell Lymphoma and Impact on Survival, a Lyma-Genomic Project Conducted on Behalf of the Lysa Group

Deciphering the Chronology of Copy Number Alterations in Multiple Myeloma (MM): What Comes First?

Landscape of Recurrent Mutations in Non-Coding Genome with Functional Implications in Newly-Diagnosed Multiple Myeloma

Bone Marrow Microenvironment Regulates Alternative Splicing Events in Myeloma Cells through Downregulation of RNA Binding Protein Fox2

in Multiple Myeloma, High-Risk Features Are Modulated By Other Chromosomal changes : A Large Snparray IFM Study

Functional and Molecular Impact Of Dp1-Dependent Alternate Splicing In Multiple Myeloma

Bone Marrow Microenvironment Affects The Pathogenesis Of Multiple Myeloma Through Downregulation Of Alternative Splicing Factor Fox2 In Myeloma Cells

Low Level Of NF-Kb Activity Is Associated With Higher Response Rate To Bortezomib-Based Induction Therapy In Patients With Newly Diagnosed Multiple Myeloma

Cereblon (CRBN) Splicing Could Influence Response To IMiDs : A New PCR Strategy to Easily Detect and Semi-Quantify Loss Of The IMiDs Binding Domain

Whole Exome Sequencing Of Multiple Myeloma Reveals An Heterogeneous Clonal Architecture and Genomic Evolution

Characterization of TFDP1 As Novel Regulatory Gene in Multiple Myeloma

Gene Mutations Detected by Whole-Exome Sequencing and Recurrent Cytogenetic Abnormalities Are Independent Events in Multiple Myeloma

Gene Expression Profile Alone Is Inadequate In Predicting Complete Responses In Multiple Myeloma

Bortezomib Inhibits mTOR Pathway in Multiple Myeloma Cell Lines Via Induced Expression of REDD1.

High-Resolution Genomic Profiles Identify Novel Genes and/or Chromosomal Regions with Prognostic and Oncogenic Significance in Myeloma Patients.

Molecular Prognosis in Multiple Myeloma: The IFM Experience.

Gene Expression Profiling Comparison between the Major Mature B-Cell Neoplasms and Their Normal Cellular and Anatomic Counterparts: Identification of Candidate Genes Potentially Involved in Lymphomagenesis.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only